Mucoviscidosis is a widely prevalent genetic disorder. In Poland, it affects approximately one in 4,000 newborns, as per data from the Central Statistical Office in 2020. Around 90 children with this condition were born worldwide. This illness is characterized by a severe course and there is no possibility of complete cure. However, it requires intensive treatment aimed at reducing the progression of the disease, alleviating its symptoms, and prolonging the patient's life. The treatment is multistage and includes m.. a. appropriately planned pharmacotherapy, physiotherapy, or surgical interventions. Given the altered metabolic processes, dietary therapy also plays a significant role in the treatment of mucoviscidosis.
Mycobacteriosis is delineated by:
Mucoviscidosis is a genetic disorder characterized by dysfunction in the secretory glands, resulting in the production of dense and sticky mucus. It primarily affects the digestive and respiratory systems. The gene responsible for its occurrence is situated on chromosome number seven and is inherited in a recessive manner, which implies that for the progeny to fall ill, both parents must be carriers, possessing a damaged copy of the gene. The manifestation of the disease is not gender-specific.
You have started reading a PRO article
You can preview the first chapter. To read the complete article and unlock all content, upgrade to a PRO account.